Study Description
The purpose of this open-label, single arm, multicenter extension study is to evaluate
the long-term safety and tolerability of inclisiran in participants with HeFH or HoFH who
have completed the ORION-16 or ORION-13 studies. This is an open-label, single arm, multicenter study designed to evaluate long-term
safety and tolerability of inclisiran. In addition, the study will provide participants
the opportunity to have continued access to treatment with inclisiran.
Interventions
Inclisiran
Eligibility Criteria
Key inclusion:
- Male and female participants with a diagnosis of HeFH or HoFH who completed the
ORION-16 or ORION-13 studies
- Per investigator's clinical judgment, participant derived benefit from treatment
with inclisiran in the ORION-16 or ORION-13 studies
Key exclusion:
- Participants who in the feeder inclisiran ORION-16 and ORION-13 studies either
screen failed or permanently discontinued from the treatment/study for any reason or
had serious safety or tolerability issues related to inclisiran treatment
- Any uncontrolled or serious disease, or any medical, physical, or surgical
condition, that may either interfere with participation in the clinical study or
interpretation of clinical study results, and/or put the participant at significant
risk
Novartis Investigative Site
Recruiting
Fortaleza,Ceara,60430275,Brazil
Novartis Investigative Site
Recruiting
Sao Paulo,SP,04023-900,Brazil
Novartis Investigative Site
Recruiting
Sao Paulo,SP,05403 000,Brazil
Novartis Investigative Site
Recruiting
Toulouse Cedex,31059,France
Novartis Investigative Site
Recruiting
Athens,115 27,Greece
Novartis Investigative Site
Recruiting
Ramat Gan,52621,Israel
Novartis Investigative Site
Recruiting
Jerusalem,9112001,Israel
Novartis Investigative Site
Recruiting
Modena,MO,41124,Italy
Novartis Investigative Site
Recruiting
Roma,RM,00165,Italy
Novartis Investigative Site
Recruiting
Ashrafieh,166830,Lebanon
Novartis Investigative Site
Recruiting
Rotterdam,Zuid Holland,3015 gd,Netherlands
Novartis Investigative Site
Recruiting
Amsterdam,1105 az,Netherlands
Novartis Investigative Site
Recruiting
Oslo,0514,Norway
Novartis Investigative Site
Recruiting
Gdansk,80 952,Poland
Novartis Investigative Site
Recruiting
Ljubljana,1000,Slovenia
Novartis Investigative Site
Recruiting
Bloemfontein,Free State,9301,South Africa
Novartis Investigative Site
Recruiting
Cape Town,Western Cape,7130,South Africa
Novartis Investigative Site
Recruiting
Pamplona,Navarra,31008,Spain
Novartis Investigative Site
Recruiting
A Coruna,15001,Spain
Novartis Investigative Site
Recruiting
Cordoba,Andalucia,14004,Spain
Novartis Investigative Site
Recruiting
Oviedo,Asturias,33011,Spain
Novartis Investigative Site
Recruiting
Geneve 14,1211,Switzerland
Novartis Investigative Site
Recruiting
Adana,01330,Turkey
Novartis Investigative Site
Recruiting
Ankara,06500,Turkey
Novartis Investigative Site
Recruiting
Middlesex,Ub9 6jh,United Kingdom
Excel Medical Clinical Trials LLC
Recruiting
Boca Raton,Florida,33434,United States
Seth J Baum
Cincinnati Childrens Hospital MC .
Recruiting
Cincinnati,Ohio,45229-3039,United States
Amy Shah
Worldwide Contacts
If the location of your choosing does not feature any contact detail, please reach out using the information below.